Search

Author/Creator Ashida, Toshifumi

1. Absent X‐linked inhibitor of apoptosis protein expression in T cell blasts and causal mutations including non‐coding deletion. Issue 1 (10th February 2022)

Authors:
Abdrabou, Shimaa Said Mohamed Ali; Toita, Nariaki; Ichihara, Shin; Tozawa, Yusuke; Takahashi, Michiko; Fujiwara, Shin‐ichi; Ashida, Toshifumi; Ohara, Osamu; Ariga, Tadashi; Manabe, Atsushi; Konno, Mutsuko; Yamada, Masafumi
Journal:
Pediatrics international
Issue:
Volume 64:Issue 1(2022)
Page Start:
n/a
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. AJM300 (carotegrast methyl), an oral antagonist of α4-integrin, as induction therapy for patients with moderately active ulcerative colitis: a multicentre, randomised, double-blind, placebo-controlled, phase 3 study. (July 2022)

Authors:
Matsuoka, Katsuyoshi; Watanabe, Mamoru; Ohmori, Toshihide; Nakajima, Koichi; Ishida, Tetsuya; Ishiguro, Yoh; Kanke, Kazunari; Kobayashi, Kiyonori; Hirai, Fumihito; Watanabe, Kenji; Mizusawa, Hidehiro; Kishida, Shuji; Miura, Yoshiharu; Ohta, Akira; Kajioka, Toshifumi; Hibi, Toshifumi; Motoya, Sato...
Journal:
Lancet gastroenterology and hepatology
Issue:
Volume 7:Number 7(2022)
Page Start:
648
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Circulating Interleukin 6 and Albumin, and Infliximab Levels Are Good Predictors of Recovering Efficacy After Dose Escalation Infliximab Therapy in Patients with Loss of Response to Treatment for Crohn's Disease: A Prospective Clinical Trial. Issue 9 (September 2015)

Authors:
Suzuki, Yasuo; Matsui, Toshiyuki; Ito, Hiroaki; Ashida, Toshifumi; Nakamura, Shiro; Motoya, Satoshi; Matsumoto, Takayuki; Sato, Noriko; Ozaki, Kunihiko; Watanabe, Mamoru; Hibi, Toshifumi
Journal:
Inflammatory bowel diseases
Issue:
Volume 21:Issue 9(2015:Sep.)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Infliximab Extends the Duration until the First Surgery in Patients with Crohn's Disease. (26th November 2013)

Authors:
Sakatani, Aki; Fujiya, Mikihiro; Ito, Takahiro; Inaba, Yuhei; Ueno, Nobuhiro; Kashima, Shin; Tominaga, Motoya; Moriichi, Kentaro; Okamoto, Kotaro; Tanabe, Hiroki; Ikuta, Katsuya; Ohtake, Takaaki; Kono, Toru; Furukawa, Hiroyuki; Ashida, Toshifumi; Kohgo, Yutaka
Other Names:
Kuramochi Hidekazu Academic Editor.
Journal:
BioMed research international
Issue:
Volume 2013(2013)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Long-Term Clinical Effectiveness of Ustekinumab in Patients With Crohn's Disease: A Retrospective Cohort Study. Issue 4 (28th July 2020)

Authors:
Ito, Takahiro; Maemoto, Atsuo; Katsurada, Takehiko; Tanaka, Hiroki; Motoya, Satoshi; Ueno, Nobuhiro; Fujiya, Mikihiro; Ashida, Toshifumi; Hirayama, Daisuke; Nakase, Hiroshi
Journal:
Crohn's & colitis 360
Issue:
Volume 2:Issue 4(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗